Alpha Layer / Signal Explorer

Signal Explorer

10-K · 10-Q · 8-K · last 6 months · ← back to feed

Clear ×
Disc Medicine, Inc. IRON

Showing 10-K, 10-Q & 8-K from the last 6 months. Need full history or all form types?

Oct 19, 2026 8-K 11 signals fired
Other
Kol Endorsement Fda Aligned Interim Data Positive Expanded Access Program Active Publication Positive Enrollment Ahead Of Schedule
Core
Secondary Endpoint Mentioned Clinical Trial Result Lead Asset Progress Indication Expansion Clinical Hold
Jul 30, 2026 10-Q 39 signals fired · top 15
Other
Net Loss Reported Financing Activities Cash Flow Disclosure Quarterly Tax Provision Benefit Disclosure Erisa Definition Or Compliance Statement Severance Payment Obligation Executive Severance Change Of Control Personnel Cost Decrease Disclosure Cash Flow Statement Investing Activities Other Income Expense Disclosure Cybersecurity Breach Reputational Harm Disclosure Liquidity Position Snapshot Disclosed Interim Data Positive Fair Value Hierarchy Reconciliation Disclosed
Core
Clinical Trial Result Regulatory Designation Only
Jul 30, 2026 8-K 12 signals fired
Other
Net Loss Reported Sga Expense Comparison Disclosed Revenue Increase Attribution Disclosure Expanded Access Program Active Interim Data Positive Patient Retention High Enrollment Ahead Of Schedule Fda Aligned
Core
Clinical Trial Result Lead Asset Progress Clinical Hold
Biotech Risk
Crl Received
Jun 24, 2026 8-K 1 signal fired
Other
Classified Board Director Election
May 5, 2026 10-Q 34 signals fired · top 15
Other
Liquidity Position Snapshot Disclosed Net Loss Reported Quarterly Tax Provision Benefit Disclosure Financing Activities Cash Flow Disclosure Market Volatility Risk Disclosure Material Weakness In Internal Controls Disclosed Other Income Expense Disclosure Cash Flow Statement Investing Activities Fair Value Hierarchy Reconciliation Disclosed Ipo Or Capital Raising Completion Nol Carryforward Expiration Disclosure Nol Tax Credit Carryforward Institutional Investment Capital Raising Uncertainty Disclosed
Core
Lead Asset Progress
May 5, 2026 8-K 8 signals fired
Other
Net Loss Reported Sga Expense Comparison Disclosed Enrollment Ahead Of Schedule Interim Data Positive Expanded Access Program Active Protocol Amended
Core
Clinical Trial Result Lead Asset Progress